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Abstract 
We report the case of a 64-year-old male presenting with a 
rapidly enlarging painful violaceous plaque in the left buttock and 
posterior thigh, following a gluteal intramuscular injection of 
benzathine penicillin. Associated urinary incontinence and lower 
left limb paresis were consistent with sciatic and lower sacral nerve 
damage, as confirmed by electromyography. Additional underlying 
muscular damage was observed in ultrasound and computer 
tomodensitometry scans and supported by high serum levels of 
creatine kinase and lactate dehydrogenase. Aggressive treatment 
was performed with fluid expansion, intravenous steroid bolus, 
vasodilators and anticoagulation, resulting in slow improvement of 
cutaneous and muscular lesions. However, no significant effect was 
observed on neurologic dysfunction after 6 months of regular 
neuromuscular rehabilitation. Nicolau Livedoid Dermatitis is a rare 
and potentially fatal condition showing variable levels of tissue 
impairment and unpredictable course and prognosis. Specific 
treatment is not consensual and the efficacy of any particular 
treatment remains to be established.  
 
Introduction 
Nicolau Livedoid Dermatitis is a rare condition consisting in 
tissue ischemia and necrosis following severe reduction of blood 
flow as a consequence of accidental vascular damage because of 
parenteric drug administration. Its evolution is highly 
unpredictable, showing variable cutaneous, muscular and bone 
impairment. Systemic infection and renal dysfunction following 
rhabdomyolysis can often cause death. 
 
Case report 
A 64-year old male was observed in the Emergency Room 
with a large acute violaceous edematous plaque of the left buttock 
and posterolateral aspect of the proximal thigh (Figure 1). The 
rapidly enlarging lesion presented with a cold livedoid surface and 
expanding reticular borders. It arose less than one hour after a left 
gluteal intramuscular injection of benzathine penicillin (2,400,000 
units); the needle puncture was still visible in the centre of the 
plaque, on the gluteal upper outer quadrant. Penicillin was 
prescribed in a Department of Infectious Disease in this patient 
with a history of late syphilis and suspicion of recent reinfection. 
The patient described involuntary urine loss immediately following 
the injection and reported severe pain in the affected area. 
 
The diagnosis of syphilis was 
first made ten years before in the 
Department of Infectious Disease, 
following a non-pruriginous 
generalized erythematous skin 
eruption. The patient was treated 
with benzathine penicillin for 
several times in that period, 
without noticeable adverse 
effects. The patient was a heavy 
smoker, had a long history of 
alcohol abuse, and was suffering 
from arterial hypertension, 
alcohol-induced chronic liver 
disease and chronic obstructive 
pulmonary disease. 
On admission, the patient was conscious, afebrile, and 
hemodynamically stable, showing no signs of peripheral 
 
Figure 1
Figure 1. Painful livedoid 
violaceous plaque in the left 
buttock and posterior thigh. The 
place of the intramuscular 
injection can be easily seen nearly 
in the centre of the plaque.
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hypoperfusion. Apart from the described livedoid plaque, a 
severe left lower limb paresia was also observed (muscular strength 
0/5, according to the Medical Research Council scale), in 
association with left patellar and Achilles areflexia and a left sock-
pattern hypoesthesia. Serum analysis revealed high levels of 
creatine kinase (22,805 U/L – normal below 171 U/L) and lactate 
dehydrogenase (536 U/L – normal below 248 U/L), suggesting 
severe muscular damage; erythrocyte sedimentation rate, plasma C-
reactive protein, white cell count, and other inflammation markers, 
hemostatic tests, and renal function parameters were within normal 
range. Local soft tissue ultrasound revealed gluteus maximus 
muscle heterogeneity and a thin interaponeurotic effusion, which 
were later confirmed by CT. No evidence of left lower limb arterial 
compromise was observed during arterial Doppler ultrasound. 
The diagnosis of Nicolau Livedoid Dermatitis was therefore 
established. The patient was admitted to the Department of 
Dermatology and submitted to aggressive treatment with dextran 
and other intravenous fluid infusions, intravenous 
methylprednisolone (1 g) as a daily bolus for 3 days, oral 
nifedipine (30 mg daily), oral pentoxyphilin (300 mg TID), and 
subcutaneous sodium enoxaparine (1 mg/kg b.i.d). Lower left limb 
neurologic impairment was confirmed by electromyography and 
described as a severe acute left lumbosacral radiculopathy (L5-S1), 
compatible with sciatic nerve injury. In addition, a 
bulbospongiosus muscle dysfunction was discerned, suggesting 
lower sacral nerve damage. 
 
No additional purpuric or necrotic areas were observed on the 
skin apart from late ecchymotic lesions on dorsal scrotum arising 
on the 6th day, justifying reduction of anticoagulant therapy to a 
prophylactic sodium enoxaparin dose of 40 mg daily. Cutaneous 
lesions showed slow progressive improvement and became 
inapparent on day 19. Muscular changes remained stable. Periodic 
serum analysis revealed normal muscular enzyme levels on day 13, 
with no associated evidences of renal dysfunction. By this stage, 
the patient started a regular program of left lower limb and bladder 
neuromuscular rehabilitation under surveillance of a neurologist 
and a physiatrist. Despite this effort, neither the lower limb 
muscular activity nor the urinary incontinence showed 
improvement after six months of specific treatment. 
 
Discussion 
Nicolau Livedoid Dermatitis, also known as Embolia Cutis 
Medicamentosa, is a rare and potentially deadly adverse event 
associated with parenteral drug administration, most commonly 
observed shortly after intramuscular, intra-articular or 
subcutaneous drug injection. Its mechanisms are not totally 
understood, but accidental intra or para-arterial drug injection 
seems to be responsible. An initial vascular injury with local 
inflammation, reflex arterial spasm, local arterial thrombosis, and 
distal vascular occlusion by microemboli would result in distal 
blood flow reduction, leading to ischemia and eventually necrosis 
of the distal tissues [1, 2, 3, 4]. Several drugs have been described 
in association with Nicolau Livedoid Dermatitis, mostly 
intramuscular antibiotics [3, 5, 6, 7] and non-steroidal anti-
inflammatory drugs [3, 4, 8, 9, 10, 11, 12]. Other drugs such as 
intramuscular vaccines [2, 13], vitamin K [14], cianocobalamine 
[3], thiocolquicoside [15], bismuth [8], intra-articular piroxicam 
[16] and glucocorticoids [17], subcutaneous interferon [4, 18], and 
sclerotherapy agents [19] have also been reported as possible 
causes. Neither the nature of the drug nor any specific 
immunologic phenomenon appear to play a significant role [2, 3, 
4]. Severe skin ulceration [8, 10, 13, 15] and rhabdomyolysis [8, 9] 
are common and consequent renal insufficiency, sepsis, or death 
may occur. 
  
Figure 2 Figure 3
Figure 2. Late purpuric lesion on dorsal scrotum arising on Day 6 
 
Figure 3. Complete resolution of skin lesions on Day 19
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In the present case, accidental damage to the inferior gluteal 
artery very probably occurred during gluteal intramuscular 
injection. This terminal branch of the anterior division of the 
internal iliac artery follows the sciatic nerve along the deep surface 
of the gluteus maximus muscle and is responsible for the 
innervation of gluteal and posterior thigh cutaneous areas and 
underlying muscles. One of its main branches, the internal 
pudendal artery, innervates the perineum, scrotum and also the 
proximal urethra and urogenital diaphragm, which may explain the 
occurrence of late cutaneous lesions in the scrotum and urinary 
incontinence. 
Neurologic impairment has been rarely described in most 
cases of Nicolau Livedoid Dermatitis [7, 16]. In this case, inferior 
gluteal artery blood flow reduction might have also compromised 
the irrigation of both proximal sciatic and pudendal nerves, 
resulting in severe irreversible lower limb and vesicle sphincter 
dysfunction. However, direct nerve damage following gluteal 
injection cannot be excluded. 
The diagnosis of Nicolau Livedoid Dermatitis is based on 
clinical presentation because there are no specific diagnostic tests. 
In fact, cutaneous biopsy appears not to be useful (showing in most 
cases cutaneous necrosis, non-specific dermal inflammation, and 
thrombosis of small to medium sized vessels) [2, 4, 13] and might 
precipitate severe local ulcers and infection. Considering its 
potentially devastating effects, Nicolau Livedoid Dermatitis should 
be promptly considered in any patient presenting with local pain 
and livedoid erythema after parenteral drug administration. Even 
when following all the safety recommendations for intramuscular 
drug injections, the risk of Nicolau Livedoid Dermatitis cannot be 
totally eliminated [2, 4]. 
Treatment is far from being consensual. Intravenous vascular 
expansion, vasodilators, anticoagulants, and systemic steroids are 
commonly used [3, 4, 8, 9, 19], with variable results. It remains 
unclear whether the various therapeutic approaches change the 
natural course of the condition and lead to a better prognosis 
because tissue damage develops rapidly and is rarely fully 
reversible. In the present case, the described treatment was 
effective in the resolution of cutaneous and muscular disease, but 
clearly insufficient for restoring normal nerve function. 
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